AU1403501A - Novel composition and use - Google Patents
Novel composition and useInfo
- Publication number
- AU1403501A AU1403501A AU14035/01A AU1403501A AU1403501A AU 1403501 A AU1403501 A AU 1403501A AU 14035/01 A AU14035/01 A AU 14035/01A AU 1403501 A AU1403501 A AU 1403501A AU 1403501 A AU1403501 A AU 1403501A
- Authority
- AU
- Australia
- Prior art keywords
- novel composition
- novel
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927121.5A GB9927121D0 (en) | 1999-11-16 | 1999-11-16 | Novel composition and use |
GB9927121 | 1999-11-16 | ||
GB0013238A GB0013238D0 (en) | 2000-05-31 | 2000-05-31 | Novel composition and use |
GB0013238 | 2000-05-31 | ||
PCT/GB2000/004363 WO2001035940A2 (fr) | 1999-11-16 | 2000-11-16 | Nouvelle composition et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1403501A true AU1403501A (en) | 2001-05-30 |
Family
ID=26244395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14035/01A Abandoned AU1403501A (en) | 1999-11-16 | 2000-11-16 | Novel composition and use |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1231917A2 (fr) |
JP (1) | JP2003514011A (fr) |
AU (1) | AU1403501A (fr) |
WO (1) | WO2001035940A2 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030920A1 (es) | 1999-11-16 | 2003-09-03 | Smithkline Beecham Plc | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones |
EP1278513B1 (fr) * | 2000-05-01 | 2007-07-18 | Aeropharm Technology, LLC | Formulation de noyaux |
JP2004536841A (ja) * | 2001-07-10 | 2004-12-09 | エアロファーム テクノロジー インコーポレイテッド | コア製剤 |
JP2004536842A (ja) * | 2001-07-10 | 2004-12-09 | エアロファーム テクノロジー インコーポレイテッド | トログリタゾンおよびビグアナイドを含むコア製剤 |
KR100897890B1 (ko) * | 2002-06-17 | 2009-05-18 | 인벤티아 헬스케어 피브이티. 엘티디. | 티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법 |
CN100367960C (zh) * | 2002-07-11 | 2008-02-13 | 武田药品工业株式会社 | 包衣制剂的制备方法 |
US7785627B2 (en) * | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
ES2529180T3 (es) * | 2002-09-20 | 2015-02-17 | Andrx Labs Llc | Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona |
US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
UA80991C2 (en) * | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
JP4567340B2 (ja) * | 2003-01-29 | 2010-10-20 | 武田薬品工業株式会社 | 被覆製剤の製造方法 |
UA86015C2 (ru) * | 2003-01-29 | 2009-03-25 | Такеда Фармасьютикал Компани Лимитед | Способ получения твердой лекарственной формы с покрытием |
US7976853B2 (en) * | 2003-01-29 | 2011-07-12 | Takeda Pharmaceutical Company Limited | Process for producing coated preparation |
GB0318824D0 (en) * | 2003-08-11 | 2003-09-10 | Glaxo Group Ltd | Novel composition |
CA2562391A1 (fr) * | 2004-04-14 | 2005-10-27 | Takeda Pharmaceutical Company Limited | Preparation pharmaceutique solide |
WO2010136847A1 (fr) * | 2009-05-26 | 2010-12-02 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Metformine enrobée d'une solution de pioglitazone |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9810172A (pt) * | 1997-06-18 | 2000-08-08 | Smithkline Beecham Plc | Tratamento de diabete com tiazolidinadiona e metformina |
GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
CA2320900C (fr) * | 1998-03-19 | 2009-10-27 | Bristol-Myers Squibb Company | Systeme d'apport a liberation lente biphasique destine a des medicaments a solubilite elevee et procede associe |
-
2000
- 2000-11-16 WO PCT/GB2000/004363 patent/WO2001035940A2/fr not_active Application Discontinuation
- 2000-11-16 AU AU14035/01A patent/AU1403501A/en not_active Abandoned
- 2000-11-16 EP EP00976151A patent/EP1231917A2/fr not_active Withdrawn
- 2000-11-16 JP JP2001537933A patent/JP2003514011A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2001035940A3 (fr) | 2002-03-21 |
EP1231917A2 (fr) | 2002-08-21 |
JP2003514011A (ja) | 2003-04-15 |
WO2001035940A2 (fr) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL190220A0 (en) | Novel composition and use | |
AUPQ419099A0 (en) | Novel compositions and methods | |
AU3731600A (en) | Composition and structures made therefrom | |
AU4318000A (en) | Agarobiose-containing composition | |
AU5634300A (en) | Composition and films thereof | |
AU1890599A (en) | Novel microorganism and use thereof | |
AU4431000A (en) | Novel use | |
AU1403501A (en) | Novel composition and use | |
AU5567700A (en) | Hair composition | |
AU1290501A (en) | Composition | |
AU2001292047A1 (en) | Composition containing an azaphthalocyanine and use | |
AU2841801A (en) | Triazolotriazinones and the use thereof | |
EG22491A (en) | Rest-breaking composition and use thereof | |
AU1152601A (en) | Compositions and their use | |
AU2176001A (en) | Cosmetic composition | |
AU4779400A (en) | Hair-treatment composition | |
AU7026100A (en) | Dye compositions and uses | |
AU6310600A (en) | Composition | |
GB9927927D0 (en) | Compound composition and use | |
AU2399601A (en) | Novel tachykinin-like polypeptides and use thereof | |
AU2669201A (en) | Taccalonolides and their use | |
AU5979300A (en) | Angiopoietin-6 and uses thereof | |
AU5567600A (en) | Hairdye composition | |
AU5974100A (en) | 6-carboxyphenyldihydropyridazinone derivatives and use thereof | |
AU5931300A (en) | Ringene compositions and methods for use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |